Trademarkia Logo

Canada

C$
NANOSTRIPS
ABANDONED SECTION 36

on 11 Oct 2024

Last Applicant/ Owned by

NANOSTRIPS INC.

9 IslandviewIrvine, CA 92604

US

Serial Number

1965147 filed on 27th May 2019

Correspondent Address

GOWLING WLG (CANADA) LLP

550 BURRARD STREETSUITE 2300VANCOUVER

BRITISH COLUMBIA

CA

V6C2B5

NANOSTRIPS

Trademark usage description

herbal teas for medicinal purposes; medicinal herbal extracts for medical purposes; medicinal herbal preparations; pharmaceutical products and prepara Read More

Classification Information


Class [005]
Herbal teas for medicinal purposes; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Calcium supplements; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Dietary supplements; Dietary supplements for pets; Dietary food supplements; Enzyme food supplements; Food supplements; Herbal supplements; Homeopathic supplements; Hyaluronic acid for pharmaceutical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Lecithin dietary supplements; Mineral supplements; Mineral food supplements; Mineral nutritional supplements; Natural herbal supplements; Nutritional supplements; Ocular pharmaceuticals; Probiotic supplements; Propolis dietary supplements; Protein supplements; Royal jelly dietary supplements; Soy protein dietary supplements; Vitamin supplements; Medicinal herbal extracts for medical purposes derived from hemp; Medicinal herbal preparations derived from hemp; Dietary supplements derived from hemp; Dietary supplements for pets derived from hemp; Dietary food supplements derived from hemp; Enzyme food supplements derived from hemp; Food supplements derived from hemp; Herbal supplements derived from hemp; Homeopathic supplements derived from hemp; Natural herbal supplements derived from hemp; Nutritional supplements derived from hemp; Vitamin supplements derived from hemp; Pharmaceutical products and preparations derived from hemp for the prevention and treatment of dry skin caused by pregnancy, chloasma, pregnancy blemishes, skin blemishes during pregnancy, swelling in the legs, ophthalmological disorders, cancer, bone diseases, joint disease, viral and infectious diseases, respiratory diseases, asthma, erectile dysfunction, cardiovascular diseases, dermatological diseases, and anaphylactic reactions; Pharmaceutical preparations for the treatment of Post-Traumatic Stress Disorder (PTSD), anxiety, sleep, digestive disorders, namely gastric hyperactivity, gastroenteritis, nausea, gastric and stomach ulcers, intestinal inflammation, acid reflux, intestinal motility disorders, and enteritis, sexual disorders, namely, female sexual dysfunction (FSD) and erectile dysfunction (ED), low libido in both sexes, and nutrition disorders, namely mineral deficiency, vitamin deficiency and pain relief; Chemical preparations for pharmaceutical and medical purposes, namely, for Post-Traumatic Stress Disorder (PTSD), anxiety, sleep, digestive, sexual and nutrition disorders and pain relief; Medicinal herbal preparations for medical purposes, namely medical cannabis and marijuana extracts; Medicinal preparations, namely medical cannabis and marijuana extracts, for oral consumption, namely medical cannabis and marijuana extracts in the form of drops, capsules, tablets and compressed tablets; Plant extracts for pharmaceutical purposes, namely medical cannabis and marijuana extracts; Plant extracts for medical, veterinary and pharmaceutical purposes, namely medical cannabis and marijuana extracts; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for the prevention and treatment of cancer; Pharmaceutical preparations for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceuticals for the treatment of erectile dysfunction; Digestives for pharmaceutical purposes, namely pharmaceutical preparations for the treatment of gastric hyperactivity, gastroenteritis, nausea, gastric and stomach ulcers, intestinal inflammation, intestinal motility disorders acid reflux, and enteritis; Sexual stimulant gels


Classification kind code

11

Mark Details


Serial Number

1965147

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 11th Oct 2024
Abandoned - Section 36
Submitted for opposition 14
on 22nd Jul 2024
Default Notice Sent
Submitted for opposition 22
on 2th Jan 2024
Search Recorded
Submitted for opposition 20
on 2th Jan 2024
Examiner's First Report
Submitted for opposition 287
on 9th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 30th May 2019
Formalized
Submitted for opposition 1
on 28th May 2019
Created
Submitted for opposition 30
on 27th May 2019
Filed